Potiga (ezogabine)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 BOXED WARNING damage to the photoreceptors and vision loss… Macular abnormalities characterized as vitelliform lesions...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts